Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 45,880	$ 164,164
Marketable investments	204,946	0
Accounts receivable, net of allowance for credit losses of $1,504 and $899, respectively	35,876	31,449
Inventories, net	55,938	39,503
Other current assets and prepaid expenses	23,672	14,545
Total current assets	366,312	249,661
Property and equipment, net	34,479	3,019
Deferred tax assets	626	778
Goodwill	1,339	1,339
Operating lease right-of-use assets	13,033	14,627
Other long-term assets	11,668	10,169
Restricted cash	700	700
Total assets	428,157	280,293
Current liabilities:
Accounts payable	34,176	7,891
Accrued liabilities	50,791	54,100
Operating lease liabilities	2,712	2,419
Deferred revenue	10,579	9,490
Total current liabilities	98,258	73,900
Deferred revenue, net of current portion	1,822	1,335
Operating lease liabilities, net of current portion	11,642	13,483
Convertible notes, net of unamortized debt issuance costs of $8,869 and $4,007, respectively	300,256	134,243
Other long-term liabilities	685	763
Total liabilities	412,663	223,724
Commitments and Contingencies (Note 13)
Stockholders’ equity:
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 19,607,751 and 17,995,344 shares at September 30, 2022 and December 31, 2021, respectively	20	18
Additional paid-in capital	148,535	114,724
Accumulated other comprehensive loss	(336)	0
Accumulated deficit	(132,725)	(58,173)
Total stockholders’ equity	15,494	56,569
Total liabilities and stockholders’ equity	$ 428,157	$ 280,293